Pharmafile Logo

Meet OPEN Health and Pharmerit Experts at the World Orphan Drug Virtual USA Congress

August 24, 2020 |  

Join OPEN Health and Pharmerit – an OPEN Health Company at the World Orphan Drug Virtual Congress from August 24-27, 2020, as we present:

Advanced Therapies Commercial: Tuesday, August 25
Succeeding with Star Wars Medicine: Translating the Science and Value of Gene Therapy to Key Stakeholders

Gavin Jones, Director of Rare Disease, OPEN Health

PANEL: Wednesday, August 26
Bridging the Clinical Evidence Gap for Payers – Examining Recent Cases of Real-World Evidence for Reimbursement

Shelby Corman, Real-World Evidence and Data Analytics Lead, Pharmerit

Pink divider

OPEN Health is the only integrated agency that combines the depth of rare disease knowledge with the breath of discipline expertise across medical affairs, commercial, HEOR and market access.

OPEN Health’s Evidence and Access practice is a best in class global HEOR and market access consultancy that specialises in identifying client critical issues and building bespoke integrated solutions to support companies operating in rare disease and improve patient outcomes.

The Patient and Brand Communications practice at OPEN Health combines a deep focus in patient engagement (patient journey mapping and patient support programmes), PR (brand, disease awareness, corporate and internal communications) and advertising.

The Medical Communications practice provides expertise in Medical Affairs content and consultancy, publication planning and management, medical education, and internal training.

In addition to extensive rare disease experience we have delivered projects for over half the advanced therapies that have been launched in the United States and Europe.

Pink divider

Our executive team will be available to speak with you regarding how OPEN Health and Pharmerit can support you in the fight against rare diseases. Contact Gavin Jones today to set up a meeting.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access

OPEN Health Appoints Chief Medical Officer Annemarie Clegg, MD, and Chief Commercial Officer Jennifer Chilver

OPEN Health Appoints Chief Medical Officer Annemarie Clegg, MD, and Chief Commercial Officer Jennifer Chilver

Announcing OPEN Health New Communications CEO, Margot Hannah

OPEN Health is pleased to announce the appointment of Margot Hannah as the new Chief Executive Officer of OPEN Health Communications

OPEN Health Acquires ARK

OPEN Health has today announced the acquisition of London-based agency ARK to further strengthen omnichannel capabilities

Rare thoughts & outcomes – navigating pathways to better outcomes in rare

Mobilizing pathway change – what the past 25 years have shown meWelcome to OPEN Health’s second Rare Thoughts & Outcomes theme for 2021 – Navigating pathways to better outcomes. This...

How to pick the perfect training program for your healthcare professionals

You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...

Maximize your training investments with learning and development specialists

Medical affairs teams must train regularly to stay up to date with existing and emerging therapy areas, products, and devices. But finding time to train is tough, so what can...

A day in the life of a PR Account Director

We asked Laura Glover to give us an insight into her role as a PR Account Director at OPEN Health

OPEN Health acquires UK medical communications agency Spirit

OPEN Health has today announced the acquisition of North West UK-based medical communications agency Spirit.

OPEN Health Starring in the Top 100 North American Healthcare Agencies of 2021

We are delighted to announce our selection in the top 50 of 100 North American healthcare agencies as ranked by Medical, Marketing & Media (MM&M).